Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> China Pharma Providers
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
China Pharma Providers
Type:
CRO-Clinical
Title:
Convance Inc. Beijing
Chinese
CSertification:
n/a
International
Certification:
n/a
Primary Location:
Beijing
China
Contact Info:
Room 407, NCI Tower, A12 Jianguomenwai Avenue, Chaoyang District, Beijing 100022, China
Tel: +86 10 6569 4118
Webpage:
www.covance.com
HQ
Contact Info:
Convance Inc.
The Americas: +1 888 268 2623; +1 609 419 2240
Europe/Africa: +800 2682 2682; +44 1423 500 888
Asia/Pacific: +800 6568 3000; +65 6567 7333
Email: info@ covance.com
Additional
Contact Info:
Covance Central Laboratory Shanghai
Zhangjiang Hi-Tech Industrial Park, Shanghai, China
Tel: +86 21 5137 1111
Description:
Covance offers the broadest range of contract drug development services globally from preclinical through post-approval stages, including monitoring and managing clinical trials, and advising clients on global regulatory applications.
In collaboration with the China Innovation Center for Life Sciences (CICLS), an office of the Chinese Ministry of Science and Technology (MOST), and leading Chinese pharmaceutical companies, Covance will be the first company in its field to test traditional Chinese medicines for approval by the U.S. Food and Drug Administration (FDA).
Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.3 billion, global operations in more than 20 countries, and more than 8,400 employees worldwide. Offering drug development solutions from preclinical through commercialization, Covance is a world-class provider of the following service lines: Research products, Antibody products and services, Nonclinical development services, Risk management services, Clinical pharmacology services, Central laboratory/Covance local laboratory services, Cardiac safety services, Clinical development services, Commercialization services.
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit